Universität Wien FIND

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1 (2019W)

5.00 ECTS (2.00 SWS), SPL 32 - Pharmazie
Prüfungsimmanente Lehrveranstaltung

Beginn am 01.10.2019 09.00 Uhr im Raum 2D313
Vorlesungstermine:
02.10./03.10./07.10./08.10./09.10./10.10./14.10./15.10./16.10./17.10./21.10./22.10.2019 immer von 14.00-17.00 Uhr im Raum 2D313

Details

Sprache: Englisch

Lehrende

Termine (iCal) - nächster Termin ist mit N markiert

Dienstag 01.10. 09:00 - 11:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Mittwoch 02.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Donnerstag 03.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Montag 07.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Dienstag 08.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Mittwoch 09.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Donnerstag 10.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Montag 14.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Dienstag 15.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Mittwoch 16.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Donnerstag 17.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Montag 21.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Dienstag 22.10. 14:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
Mittwoch 23.10. 14:15 - 15:45 UZA2 Hörsaal 5 (Raum 2Z202) 2.OG

Information

Ziele, Inhalte und Methode der Lehrveranstaltung

The students will be introduced to basic principles in drug discovery. The course will consist of presentations given by the faculty, as well as presentations given by students, followed by round table discussions.

Art der Leistungskontrolle und erlaubte Hilfsmittel

There will be one written evaluation at the end of the course.
The grades will be deduced from the result in the written evaluation, together with taking into account class participation as well as presentation skills.
The written evaluation is done in the open book mode, i.e. students are allowed to use all the
material collected during the class and the studies for the class.

Mindestanforderungen und Beurteilungsmaßstab

The student should possess basic knowledge in principles of drug discovery. Topics will cover target identification and validation, structural biology, hit identification and validation, lead structure identification and optimization and hereby be able to understand and comprehensively and critically present original papers / projects /ideas to these topics.

Prüfungsstoff

All topics covered during the course.

Literatur

Some useful literature can be found in the following publications:
- Benjamin E. Blass: Basic Principles of Drug Discovery and Development (Academic Press, ISBN 978-0-12-411508-8)
- Raymond Hill: Drug Discovery and Development: Technology in Transition (Churchill Livingstone Elsevier, ISBN 976-0-7020-4299-7)
- Jeffrey Strovel et al.: Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies (https://www.ncbi.nlm.nih.gov/books/NBK92015/pdf/Bookshelf_NBK92015.pdf)

Zuordnung im Vorlesungsverzeichnis

Letzte Änderung: Mi 23.10.2019 15:48